Hati Health

Cover Block

PUBLIC

Name	Hati Health
Tagline	Women's health marketplace and B2B platform in Philippines [F6S]
Headquarters	Metro Manila, Philippines [SGPGrid]
Founded	2023 [The Independent Investor, June 2024]
Stage	Pre-Seed
Business Model	Marketplace
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Southeast Asia
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	Pre-seed (total disclosed ~$500,000) [The Independent Investor]

Links

PUBLIC

• Website: https://hati.health
• LinkedIn: https://www.linkedin.com/company/hatihealth

Executive Summary

PUBLIC

Hati Health is an early-stage, venture-scale bet on digitizing women's healthcare access in the Philippines, a market where offline fragmentation and social stigma create a clear opening for a trusted, integrated platform. Founded in 2023, the company operates a two-sided marketplace and B2B software platform, connecting women to a network of over 100 partner clinics and services while offering white-label AI tools to those clinics for patient management [F6S] [Hati Health FAQ]. The model attempts to address both consumer discovery and provider operational pain points in a single system.

The founding team of Maria Gaitanidou, Alex Gridnev, and Aiai Garcia launched the venture to consolidate a historically fragmented care journey. Early external validation came in June 2024 when Hati Health won the InsureTech Connect Asia Awards 2024 in Singapore, signaling recognition from adjacent financial and technology stakeholders [The Independent Investor, June 2024]. The company's disclosed pre-seed funding of approximately $500,000 is led by regional investors Forge Ventures and Wavemaker Partners, with angel participation from Ron Hose, providing a runway for initial network build-out and product development [The Independent Investor].

Over the next 12-18 months, the critical watchpoints are the translation of clinic partnerships into sustained transaction volume on the marketplace, and the commercial adoption of its B2B AI tools by healthcare providers. Success will depend on demonstrating that its integrated approach can achieve liquidity faster than a pure consumer aggregator or a standalone SaaS product for clinics.

Data Accuracy: YELLOW -- Core product and partnership claims are sourced from company materials and an industry database; funding details and award are reported by a single regional publication. Team size and some background details lack independent corroboration.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	Marketplace
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Southeast Asia (Philippines)
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	Pre-seed (~$500,000 disclosed)

Company Overview

PUBLIC

Hati Health was founded in 2023 as a digital health marketplace and B2B platform, with a stated mission to address healthcare access for women in the Philippines [Crunchbase]. The company is headquartered in Metro Manila and operates with a team size reported in the one-to-ten employee range [SGPGrid].

Its early development focused on building a network of partner clinics and launching a consumer-facing marketplace. A key milestone occurred in June 2024, when Hati Health won the InsureTech Connect Asia Awards 2024 in Singapore, an early signal of external validation in the insurtech-adjacent healthtech space [The Independent Investor, June 2024]. The company's public presence, including its website and FAQ, reports a network of over 100 partner clinics across the Philippines [Hati Health FAQ].

Data Accuracy: YELLOW -- Core company details are consistent across multiple public sources, but team size and specific milestone dates are not widely corroborated.

Product and Technology

MIXED Hati Health's product architecture is a dual-sided platform, connecting consumers to a broad network of providers while offering a software layer to the clinics themselves. The B2C marketplace consolidates access to clinics, doctors, diagnostics, and wellness products, with specific services like online consultations, lab tests, and curated care programs for conditions like PCOS highlighted on the company's website [Hati Health, Unknown]. A 24/7 AI chat assistant, the Hati Bot, is promoted for preliminary symptom advice, though its underlying model and clinical validation are not detailed in public materials [F6S, Unknown].

The B2B component is a white-label AI solution intended for partner clinics and diagnostic centers. According to the company's description, this software aims to optimize core clinic operations such as appointment scheduling, payments, and patient management [F6S, Unknown]. The technology stack powering these services is not publicly disclosed. The platform's operational foundation is its reported network of over 100 partner clinics across the Philippines, which provides the inventory for its marketplace bookings [Hati Health FAQ, Unknown].

Data Accuracy: YELLOW -- Product claims sourced from company website and F6S profile; clinic network count is company-reported.

Market Research

PUBLIC

The market for digital women's health services in the Philippines presents a specific opportunity defined by persistent access gaps and a demographic shift towards proactive care. While Hati Health's own market sizing is not publicly quantified, the operating environment can be assessed through regional trends and analogous market data.

Demand drivers are anchored in structural factors. The Philippines has a high mobile penetration rate, exceeding 150% as of 2023, which creates a ready channel for digital health adoption [GSMA, 2023]. Concurrently, rising health awareness among women, particularly concerning conditions like PCOS and cervical cancer, is increasing demand for specialized, convenient care pathways. The country's health system, characterized by a mix of public and private providers, often leaves patients navigating fragmented services, a friction point a unified marketplace aims to solve.

Adjacent and substitute markets provide context. The broader Southeast Asian digital health market was valued at approximately $6.7 billion in 2022 and is projected to grow at a compound annual rate of 17% through 2027, according to a report by Ken Research [Ken Research, 2023]. Within this, the telehealth segment is the most developed, with platforms like Doctor Anywhere and Halodoc demonstrating consumer willingness to pay for virtual consultations. Hati Health's focus on bundling virtual care with in-person diagnostics and a curated product catalog positions it as a more integrated, condition-specific alternative to general telehealth.

Regulatory and macro forces are a mixed picture. The Philippine Food and Drug Administration (FDA) regulates medical devices and pharmaceuticals sold online, adding compliance overhead for any marketplace offering pharmacy services. However, the government's Universal Health Care Act, implemented in 2019, aims to expand coverage and could create partnerships or reimbursement pathways for preventive care programs, a potential tailwind for platforms offering structured checkups and care programs.

Given the absence of a specific, cited TAM for the Philippine women's health digital marketplace, the following table presents analogous market sizing data from regional reports to frame the potential scale.

Market Segment	Size (2022/2023)	Projected CAGR	Source
Southeast Asia Digital Health	$6.7B	17% (to 2027)	Ken Research [Ken Research, 2023]
Global Women's Health Tech	$51.3B	13.3% (to 2030)	Grand View Research [Grand View Research, 2023]

The available data suggests the company is operating within a high-growth regional digital health sector, though its specific addressable market remains unconfirmed. The global growth trajectory for women's health technology indicates strong investor interest in the category, which may support future fundraising for regional players.

Data Accuracy: YELLOW -- Market sizing relies on analogous regional and global reports; specific Philippines-focused TAM for women's health digital platforms is not publicly available from cited sources.

Competitive Landscape

MIXED

Hati Health enters a fragmented Philippine healthcare market by attempting to consolidate a specific user journey, women's health, across both consumer and business channels. This positioning creates a competitive map with distinct layers, from broad generalist platforms to niche specialists.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Hati Health	Women's health marketplace & B2B platform in the Philippines	Pre-seed (~$500k)	Dual B2C/B2B focus with white-label AI for clinics; 100+ partner clinic network [PUBLIC]	[F6S] [Hati Health FAQ]

The table highlights a scarcity of directly comparable, publicly funded women's health marketplaces in the Philippines. The single named competitor, Kindred, lacks public details on its model or funding, making a direct feature-for-feature comparison impossible at this stage. This absence is itself a data point: the competitive field appears nascent, defined more by category adjacency than by head-to-head combat.

The segment-by-segment map reveals competition on several fronts. For the B2C marketplace, Hati Health contends with generalist health booking platforms like KonsultaMD and NowServing, which offer broader doctor directories but lack a dedicated women's health curation. Adjacent substitutes include direct-to-consumer wellness apps and telehealth services from large hospital networks, which capture specific service lines like consultations or diagnostics. On the B2B side, the white-label AI offering for clinics competes with practice management software vendors and the internal IT systems of larger hospital groups, where the value proposition shifts from patient acquisition to operational efficiency.

Hati Health's current defensible edge appears to be its early-mover focus on aggregating women's health services and its claimed network of over 100 partner clinics [Hati Health FAQ]. This edge is perishable, however, as it relies on exclusive or preferential contracts that are not publicly confirmed. The dual-sided marketplace model also creates a classic chicken-and-egg problem; the value to clinics depends on user volume, and user adoption depends on clinic breadth and quality. Without rapid scaling on both sides, this edge could be eroded by a better-funded generalist platform deciding to create a dedicated women's health vertical.

The company is most exposed on two flanks. First, to generalist platforms with significantly larger user bases and marketing budgets, which could replicate a curated women's health experience as a feature rather than a standalone product. Second, to a potential inability to secure deeper integrations with partner clinics beyond basic booking, which would limit the defensibility of its B2B AI tools. If clinics view Hati primarily as a lead-generation channel rather than a core operational partner, the platform risks being disintermediated.

The most plausible 18-month competitive scenario hinges on execution speed and capital. If Hati Health can rapidly convert its clinic network into exclusive, integrated partnerships and demonstrate clear patient volume, it could become the category-defining brand for women's health in the Philippines, a winner in a segment-specific land grab. If execution lags or funding remains constrained, it becomes a loser to market saturation, as larger players or new entrants with more capital replicate the model and outspend on customer acquisition, relegating Hati to a niche player or an acquisition target for its clinic relationships.

Data Accuracy: YELLOW -- Competitive analysis is limited by sparse public data on direct competitors; Hati's own network claims are sourced from its website.

Opportunity

PUBLIC A successful execution could position Hati Health as the dominant transactional and operational layer for women's healthcare in a region where digital adoption is accelerating and traditional access remains fragmented.

The headline opportunity is to become the default digital health marketplace and clinic operating system for women in the Philippines, and eventually Southeast Asia. This outcome is reachable because the company's initial wedge, a network of over 100 partner clinics, directly addresses a core friction point: connecting patients to trusted, vetted providers [Hati Health FAQ]. The business model is dual-sided, capturing both consumer transaction fees and B2B software subscriptions, which provides multiple paths to monetization. The recent InsureTech Connect Asia award in 2024 signals early recognition from adjacent financial and technology stakeholders, suggesting a potential to integrate health services with insurance and payment flows [The Independent Investor, June 2024].

Growth is not a single path; the company's structure suggests several plausible, high-scale scenarios.

Scenario	What happens	Catalyst	Why it's plausible
National Platform Dominance	Hati becomes the primary booking and care coordination tool for women's health services across the Philippines.	A major national pharmacy chain or insurer adopts the white-label AI for its clinics, standardizing the platform across hundreds of locations.	The company's stated B2B focus on clinics and diagnostic centers indicates a strategy built for institutional adoption, not just direct-to-consumer traction [F6S].
Regional Expansion as a B2B SaaS	The white-label clinic software becomes the preferred patient management system for women's health providers across Southeast Asia.	A successful Series A round is used to fund expansion into Indonesia and Vietnam, targeting clinics with similar fragmentation and digitalization needs.	The underlying technology stack (AI for scheduling, payments) is geographically agnostic, and regional investors like Forge Ventures often back cross-border plays [Crunchbase].
Integrated Health & Insurtech Leader	Hati evolves into a bundled health-insurance product, managing preventative care programs and claims for corporate and individual clients.	A strategic partnership with a major regional insurer to co-create and distribute a women's health-focused insurance plan.	Winning an insurtech award demonstrates the company is already on the radar of that ecosystem, framing its services in a language insurers understand [The Independent Investor, June 2024].

Compounding success would likely follow a classic platform flywheel. More partner clinics improve geographic coverage and service selection, attracting more users to the marketplace. Increased user traffic and transaction volume generate more data, which can refine the AI assistant's advice and optimize the clinic software's scheduling algorithms. Better tools and more patient flow increase clinic retention on the B2B software, creating a distribution lock-in. While still early, the public claim of a 100+ clinic network is the initial evidence this flywheel has begun to spin [Hati Health FAQ].

Quantifying the size of the win requires looking at comparable models. The closest public analogue in a similar, albeit larger, market is Practo in India, which reached a reported valuation of approximately $1.5 billion at its peak as a doctor-discovery and clinic management platform [Various]. For Hati, a National Platform Dominance scenario in the Philippines, a country of over 110 million people, could support a valuation in the high hundreds of millions. A successful Regional Expansion as a B2B SaaS scenario, capturing a meaningful share of clinic operations in multiple Southeast Asian markets, could support a valuation exceeding $1 billion (scenario, not a forecast). The total addressable market for digital health in Southeast Asia is projected to grow significantly, though specific women's health segment figures are not publicly available in cited sources.

Data Accuracy: YELLOW -- Opportunity framing is extrapolated from confirmed product claims and a single award citation; market size and comparable valuation lack specific, recent citations.

Sources

PUBLIC

1. [F6S] Hati Health | https://www.f6s.com/company/hati-health

2. [Hati Health FAQ] What is Hati Health | https://hati.health/faq/what-is-hati-health

3. [The Independent Investor, June 2024] PH women’s health platform Hati Health wins Insurtech award at ITC Asia 2024 Singapore | https://theindependentinvestor.ph/ph-womens-health-platform-hati-health-wins-insurtech-award-at-itc-asia-2024-singapore/

4. [Crunchbase] Hati Health | https://www.crunchbase.com/organization/hati-health

5. [SGPGrid] Hati Health | https://sgpgrid.com/company/hati-health-ID0001

6. [GSMA, 2023] The Mobile Economy Asia Pacific 2023 | https://www.gsma.com/mobileeconomy/asiapacific/

7. [Ken Research, 2023] Southeast Asia Digital Health Market Outlook to 2027 | https://www.kenresearch.com/healthcare/healthcare-services/southeast-asia-digital-health-market/143519-91.html

8. [Grand View Research, 2023] Women's Health Technology Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/womens-health-technology-market-report